4YC-67828-11393
5 vaccinations
9 coded responses
45 check-ins
6 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 741 / OK
- Registered
- 2021-03-18
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-17
Dose 1 — Pfizer-BioNTech
-
2021-03-18
Registered in v-safe
- 2021-03-18
- 2021-03-20
- 2021-03-21
- 2021-03-23
- 2021-03-24
- 2021-03-31
-
2021-04-07
Dose 2 — Pfizer-BioNTech
-
2021-04-07
Health check-in — day 0, dose 2Feeling: Good · Headache · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-08
Survey response — days 1–6 daily, dose 2MedDRA: Asthma — Feeling: Fair · Fever · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Asthma-like symptomsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-09
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-04-11
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fever · Chills, Fatigue or tiredness, Diarrhea · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-12
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fever · Chills, Fatigue or tiredness, Diarrhea · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-13
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-04-14
- 2021-04-22
- 2021-04-29
- 2021-05-07
-
2021-05-14
Survey response — day 35, dose 2MedDRA: Hospitalisation, Nephrolithiasis, Sepsis — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · HospitalizationFree text: Sepsis and kidney stone in hospitalMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-14
Report sent to call center — day 35, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-05-19
-
2021-07-07
Survey response — 3 months, dose 2MedDRA: Urinary tract infection — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, HospitalizationFree text: Recurrent UTI.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-07
Report sent to call center — 3 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-07-12
- 2021-10-08
-
2021-12-02
Dose 3 — Pfizer-BioNTech
- 2022-04-07
-
2022-06-14
Dose 4 — Pfizer-BioNTech
-
2022-06-14
Health check-in — day 0, dose 4Feeling: Good · Site: Pain · Fever · Fatigue or tirednessAdult check-in
-
2022-06-16
Survey response — days 1–6 daily, dose 4MedDRA: Ageusia, SARS-CoV-2 test negative — Feeling: Good · Joint pains, Muscle or body achesFree text: Loss of taste; covid test negativeMedDRA releases: 2024-11 · check-in free text available
- 2022-06-17
- 2022-06-18
- 2022-06-19
-
2022-06-21
Health check-in — day 7, dose 4Feeling: Fair · Headache · Be unable to do your normal daily activitiesAdult check-in
- 2022-06-28
- 2022-07-05
-
2022-07-12
Survey response — day 28, dose 4MedDRA: Ageusia — Feeling: FairFree text: Within 12 hours of the most recent booster, I lost my sense of taste. It lasted 2-3 days. 4 days ago, this recurred for the 2nd time. Both the first and second recurrences lasted about 36 hours. In my life, I had lost taste & smell once before.MedDRA releases: 2024-11 · check-in free text available
- 2022-07-19
- 2022-07-26
-
2022-12-15
Dose 5 — Pfizer-BioNTech
- 2022-12-16
-
2022-12-17
Survey response — days 1–6 daily, dose 5MedDRA: Chemotherapy, Pre-existing disease — Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tiredness, DiarrheaFree text: I am on low-dose chemo for autoimmune problems. Don't know how much is vaccine & how much is other problems.oMedDRA releases: 2024-11 · check-in free text available
-
2022-12-19
Health check-in — days 1–6 daily, dose 5Feeling: Fair · Joint pains, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2022-12-20
Health check-in — days 1–6 daily, dose 5Feeling: Fair · Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2022-12-21
Health check-in — days 1–6 daily, dose 5Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to do your normal daily activitiesAdult check-in
- 2022-12-22
- 2022-12-30
- 2023-01-05
-
2023-01-12
Survey response — day 28, dose 5MedDRA: Arthralgia, Medical counselling — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationMedDRA releases: 2024-11
-
2023-01-12
Report sent to call center — day 28, dose 5Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2023-01-13
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2023-01-13
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2023-01-13
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2023-01-19
- 2023-01-26
-
2023-03-16
Survey response — 3 months, dose 5MedDRA: Upper respiratory tract infection — Feeling: Fair · Be unable to do your normal daily activitiesMedDRA releases: 2024-11
-
2023-06-17
Survey response — 6 months, dose 5MedDRA: Hypersensitivity, Pre-existing disease — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-17 | Pfizer-BioNTech | |
| 2 | 2021-04-07 | Pfizer-BioNTech | |
| 3 | 2021-12-02 | Pfizer-BioNTech | No |
| 4 | 2022-06-14 | Pfizer-BioNTech | No |
| 5 | 2022-12-15 | Pfizer-BioNTech | No |
Call center
3 call center cases
3 successful
Free text
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): Asthma-like symptoms
Release 8 — day 35, dose 2
Symptoms: Sepsis and kidney stone in hospital
Release 9 — 3 months, dose 2
Symptoms: Recurrent UTI.
Release 12 — days 1–6 daily, dose 4
Systemic reaction (other): Loss of taste; covid test negative
Release 12 — day 28, dose 4
Symptoms: Within 12 hours of the most recent booster, I lost my sense of taste. It lasted 2-3 days. 4 days ago, this recurred for the 2nd time. Both the first and second recurrences lasted about 36 hours. In my life, I had lost taste & smell once before.
Release 12 — days 1–6 daily, dose 5
Systemic reaction (other): I am on low-dose chemo for autoimmune problems. Don't know how much is vaccine & how much is other problems.o
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Ageusia | · | · | ✓ |
| SD | Arthralgia | · | · | ✓ |
| SD | Hospitalisation | ✓ | ✓ | ✓ |
| SD | Hypersensitivity | · | · | ✓ |
| SD | Medical counselling | · | · | ✓ |
| SD | Nephrolithiasis | ✓ | ✓ | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Sepsis | ✓ | ✓ | ✓ |
| SD | Upper respiratory tract infection | · | · | ✓ |
| SD | Urinary tract infection | ✓ | ✓ | ✓ |
| SRO | Ageusia | · | · | ✓ |
| SRO | Asthma | ✓ | ✓ | ✓ |
| SRO | Chemotherapy | · | · | ✓ |
| SRO | Pre-existing disease | · | · | ✓ |
| SRO | SARS-CoV-2 test negative | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release